Novel phenothiazine/donepezil-like hybrids endowed with antioxidant activity for a multi-target approach to the therapy of alzheimer’s disease

HIGHLIGHTS

  • who: Alessia Carocci et al. from the Department of Pharmacy-Pharmaceutical Sciences, University of Bari Aldo Moro, via EOrabona, Bari, Italy have published the research: Novel Phenothiazine/Donepezil-like Hybrids Endowed with Antioxidant Activity for a Multi-Target Approach to the Therapy of Alzheimer’s Disease, in the Journal: Antioxidants 2022, 1631 of 19/08/2022
  • what: The authors propose a new series of hybrid molecules obtained by linking a phenothiazine moiety known for its antioxidant properties with N-benzylpiperidine or N-benzylpiperazine fragments mimicking the core substructure of DPZ. Over the past twenty years . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?